SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
25-Apr-18 4:57 PM View: | Argos Therapeutics Inc (ARGS) | 25-Apr-18 | Disposition | 27,150 | -- | -- | (58%) 47.21K to 20.06K | |
30-Mar-18 5:13 PM View: | Argos Therapeutics Inc (ARGS) | 28-Mar-18 | Grant | 27,150 | -- | -- | 135% 20.06K to 47.21K | |
12-Jan-18 1:55 PM View: | Argos Therapeutics Inc (ARGS) | 09-Jan-18 | Market Sale (Planned) | 100,250 | $0.16 | $16,501.20 | (20%) 500.24K to 399.99K | 92% |
05-Jan-18 12:04 PM View: | Argos Therapeutics Inc (ARGS) | 03-Jan-18 | Market Sale (Planned) | 92,001 | $0.16 | $15,060.60 | (16%) 592.24K to 500.24K | 99% |
31-Aug-17 6:48 PM View: | Argos Therapeutics Inc (ARGS) | 30-Aug-17 | Grant | 499,445 | -- | -- | 538% 92.8K to 592.24K | |
23-Jan-17 3:03 PM View: | Argos Therapeutics Inc (ARGS) | 19-Jan-17 | Grant | 16,753 | -- | -- | 22% 76.04K to 92.8K | |
14-Jun-16 5:48 PM View: | Argos Therapeutics Inc (ARGS) | 13-Jun-16 | Grant | 10,924 | -- | -- | 17% 65.12K to 76.04K | |
12-Jan-16 9:43 AM View: | Argos Therapeutics Inc (ARGS) | 08-Jan-16 | Grant | 48,604 | -- | -- | 335% 14.51K to 63.12K | |
27-Aug-15 10:07 AM View: | Argos Therapeutics Inc (ARGS) | 20-Aug-15 | Market Purchase | 5,000 | $6.45 | $32,250.00 | 62% 8.13K to 13.13K | (100%) |
12-Feb-14 6:24 PM View: | Argos Therapeutics Inc (ARGS) | 12-Feb-14 | Conversion | 6,800 | -- | -- | 100% 0 to 6.8K |